Phase 1 Study of PRX019 in Healthy Adult Volunteers

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects.

NCT01989143 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults.

NCT06532383 ·Status: COMPLETED ·Phase: PHASE1

A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects

NCT01626976 ·Status: COMPLETED ·Phase: PHASE1

Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859

NCT02766621 ·Status: COMPLETED ·Phase: PHASE1

First In Human, Single Escalating Oral Dose Study Of PF-06882961 In Healthy Adult Subjects

NCT03309241 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn How the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy Adults

NCT06137729 ·Status: TERMINATED ·Phase: PHASE1

Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Oral Pf-06650833 In Healthy Subjects

NCT02485769 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PF-04958242 in Healthy Adult Volunteers

NCT01238679 ·Status: TERMINATED ·Phase: PHASE1

An Exploratory Phase 1 Microdose Study of PRX-105

NCT01093859 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Study of RPT193 in Healthy Adult Male Subjects

NCT06087978 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-05230907 In Healthy Volunteers

NCT01897142 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-06842874 in Healthy Participants

NCT04124653 ·Status: COMPLETED ·Phase: PHASE1

First In Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Adult Volunteers

NCT01011296 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of PF-06852231 in Healthy Subjects

NCT03217604 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn How Different Amounts and Forms of the Study Medicine Called PF-06414300 Act in Healthy Adults

NCT06659250 ·Status: COMPLETED ·Phase: PHASE1

Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of SXC-2023 in Healthy Volunteers

NCT03301298 ·Status: COMPLETED ·Phase: PHASE1

Investigation of Safety, Tolerability, Immunogenicity and Pharmacokinetics of Single-Dose of PF-06823859 in Japanese Healthy Participants

NCT05037409 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study of the Absorption, Metabolism, and Excretion of [14C] PBI-200

NCT05238337 ·Status: COMPLETED ·Phase: PHASE1

First-in-Human Study of PF-04958242 in Healthy Volunteers

NCT01159483 ·Status: COMPLETED ·Phase: PHASE1

Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants

NCT04427917 ·Status: COMPLETED ·Phase: PHASE1

Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects

NCT02070939 ·Status: COMPLETED ·Phase: PHASE1

Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of PF-06730512

NCT03146065 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults

NCT05890105 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Trial to Investigate the Safety and Tolerability of PF-06412562

NCT01914796 ·Status: COMPLETED ·Phase: PHASE1

Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]-PF-07304814 in Healthy Participants

NCT05050682 ·Status: COMPLETED ·Phase: PHASE1